The following Bill of Lading record outlines a container shipment imported into the US by BREAKTHRU BEVERAGE. This shipment is registered as coming from DIAGEO SCOTLAND LTD via Anvers,Belgium with logistic notifications handled by TRANS AMERICAN CHB, INC. Manifest records show a quanitity of 902 CAS with a total weight of 15467 Kilograms arrived on 2020-05-19 via the vessel MAERSK UTAH to the port of New York/Newark Area, Newark, New Jersey. Cargo includes products identified as net weight: 101.520 kilograms commodity code 22083071 jw black 5cl 12y 10x12 pet abv40.00%.
Carrier Code | MEDU |
Vessel | MAERSK UTAH [SG] |
Departure Port | Anvers,Belgium |
Landing Port | New York/Newark Area, Newark, New Jersey |
Manifest Qty | 902 CAS |
Manifest Weight | 15467 Kilograms |
Manifest Dimension | 23 Cubic Meters |
Place of Receipt | GRANGEMOUTH |
Port of Detination | Chicago, Illinois |
Conveyance ID | 9305300 [IMO Number/Lloyds Number] |
Transportation Mode | Vessel, containerized |
Arrival Date | 2020-05-19 |
Container # | Pieces | Description |
---|---|---|
PGTU4162340 | 18 | NET WEIGHT: 101.520 KILOGRAMS COMMODITY CODE 22083071 JW BLACK 5CL 12Y 10X12 PET ABV40.00% |
PGTU4162340 | 26 | NET WEIGHT: 258.492 KILOGRAMS COMMODITY CODE 22085011 TANQ RANGPUR 1.75L 06X01 ABV41.3 0% |
PGTU4162340 | 2 | NET WEIGHT: 941.160 KILOGRAMS COMMODITY CODE 22083071 JW BLUE 75CL 06X01 ABV40.00 % |
PGTU4162340 | NET WEIGHT: 424.800 KILOGRAMS COMMODITY CODE 22083030 DALWHINNIE 75CL 15Y 12X01 YRC ABV43.00% SHIPPER'S REFERENCE NUMBER: 653164 3/0112036791 EXPORTER'S REFERENCE NUMBER: 194 80354040 | |
PGTU4162340 | 2 | NET WEIGHT: 2751.840 KILOGRAMS COMMODITY CODE 22085011 TANQ LNDN GIN 1.75L 06X01 TRAY A BV47.30% |
PGTU4162340 | NET WEIGHT: 158.400 KILOGRAMS COMMODITY CODE 22083030 TALISKER 75CL 10Y 12X01 ABV 45.80% | |
PGTU4162340 | 48 | NET WEIGHT: 478.080 KILOGRAMS COMMODITY CODE 22086011 TANQ STRL 1.75L 06X01 ABV40.0 0% |
PGTU4162340 | 2 | NET WEIGHT: 2021.760 KILOGRAMS COMMODITY CODE 22085011 TANQ LNDN GIN 75CL 12X01 ABV47.3 0% |
PGTU4162340 | NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) | |
PGTU4162340 | SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME SAME SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) | |
PGTU4162340 | SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA | |
PGTU4162340 | PC: 21 CFR 170.3 (N)(2) SAME | |
PGTU4162340 | NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) | |
PGTU4162340 | SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME SAME SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) | |
PGTU4162340 | SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903661452 CUSTOMER PO: 4500781917 FDA | |
PGTU4162340 | PC: 21 CFR 170.3 (N)(2) SAME |
Master BOL | House BOL | Voyage Number | Bill Type | Manifest # | Update / Run Date |
---|---|---|---|---|---|
MEDUIP176700 | () | 019W | In-bond Automated | 1 | 2020-05-13 / 2020-05-20 |